Measurement of double beta decay of 100Mo to excited states in the NEMO 3 experiment

The double beta decay of 100Mo to the 0^+_1 and 2^+_1 excited states of 100Ru is studied using the NEMO 3 data. After the analysis of 8024 h of data the half-life for the two-neutrino double beta decay of 100Mo to the excited 0^+_1 state is measured to be T^(2nu)_1/2 = [5.7^{+1.3}_{-0.9}(stat)+/-0.8(syst)]x 10^20 y. The signal-to-background ratio is equal to 3. Information about energy and angular distributions of emitted electrons is also obtained. No evidence for neutrinoless double beta decay to the excited 0^+_1 state has been found. The corresponding half-life limit is T^(0nu)_1/2(0^+ --> 0^+_1) > 8.9 x 10^22 y (at 90% C.L.). The search for the double beta decay to the 2^+_1 excited state has allowed the determination of limits on the half-life for the two neutrino mode T^(2nu)_1/2(0^+ --> 2^+_1) > 1.1 x 10^21 y (at 90% C.L.) and for the neutrinoless mode T^(0nu)_1/2(0^+ --> 2^+_1) > 1.6 x 10^23 y (at 90% C.L.).Comment: 23 pages, 7 figures, 4 tables, submitted to Nucl. Phy

Neutrino Masses with "Zero Sum" Condition: mν1+mν2+mν3=0m_{\nu_1} + m_{\nu_2} + m_{\nu_3} = 0

It is well known that the neutrino mass matrix contains more parameters than experimentalists can hope to measure in the foreseeable future even if we impose CP invariance. Thus, various authors have proposed ansatzes to restrict the form of the neutrino mass matrix further. Here we propose that $m_{\nu_1} + m_{\nu_2} + m_{\nu_3} = 0$; this ``zero sum'' condition can occur in certain class of models, such as models whose neutrino mass matrix can be expressed as commutator of two matrices. With this condition, the absolute neutrino mass can be obtained in terms of the mass-squared differences. When combined with the accumulated experimental data this condition predicts two types of mass hierarchies, with one of them characterized by $m_{\nu_3} \approx -2m_{\nu_1} \approx -2 m_{\nu_2} \approx 0.063$ eV, and the other by $m_{\nu_1} \approx -m_{\nu_2} \approx 0.054$ eV and $m_{\nu_3} \approx 0.0064$ eV. The mass ranges predicted is just below the cosmological upper bound of 0.23 eV from recent WMAP data and can be probed in the near future. We also point out some implications for direct laboratory measurement of neutrino masses, and the neutrino mass matrix.Comment: Latex 12 pages. No figures. New references adde

Astronomical Distance Determination in the Space Age: Secondary Distance Indicators

The formal division of the distance indicators into primary and secondary leads to difficulties in description of methods which can actually be used in two ways: with, and without the support of the other methods for scaling. Thus instead of concentrating on the scaling requirement we concentrate on all methods of distance determination to extragalactic sources which are designated, at least formally, to use for individual sources. Among those, the Supernovae Ia is clearly the leader due to its enormous success in determination of the expansion rate of the Universe. However, new methods are rapidly developing, and there is also a progress in more traditional methods. We give a general overview of the methods but we mostly concentrate on the most recent developments in each field, and future expectations. © 2018, The Author(s)

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least 101 of 987 patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against interferon-w (IFN-w) (13 patients), against the 13 types of IFN-a (36), or against both (52) at the onset of critical disease; a few also had auto-Abs against the other three type I IFNs. The auto-Abs neutralize the ability of the corresponding type I IFNs to block SARS-CoV-2 infection in vitro. These auto-Abs were not found in 663 individuals with asymptomatic or mild SARS-CoV-2 infection and were present in only 4 of 1227 healthy individuals. Patients with auto-Abs were aged 25 to 87 years and 95 of the 101 were men. A B cell autoimmune phenocopy of inborn errors of type I IFN immunity accounts for life-threatening COVID-19 pneumonia in at least 2.6% of women and 12.5% of men